Cargando…

Decreased FOXO1 Expression Is Correlated with Poor Prognosis in Myelodysplastic Syndromes

Myelodysplastic syndrome is one of the main hematological malignancies that threaten the health of the elderly. However, biomarkers which predict the progression and prognosis of MDS are still controversial and puzzling. FOXO1 gene plays an important role in a variety of intracellular functions, inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zheng, Huang, Nanfang, Xv, Feng, Zhao, Sida, Guo, Juan, Zhao, Youshan, Chang, Chunkang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600488/ https://www.ncbi.nlm.nih.gov/pubmed/36290822 http://dx.doi.org/10.3390/curroncol29100545

Ejemplares similares

Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
por: Zhao, Youshan, et al.
Publicado: (2022)

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway
por: Zheng, Qingqing, et al.
Publicado: (2018)

P739: INCREASED FOXO1 EXPRESSION IS ASSOCIATED WITH BETTER PROGNOSIS IN MYELODYSPLASTIC SYNDROME PATIENTS RECEIVING DECITABINE THERAPY
por: Zhang, Zheng, et al.
Publicado: (2023)

High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome
por: Gu, Shucheng, et al.
Publicado: (2013)

Decitabine Induces Change of Biological Traits in Myelodysplastic Syndromes via FOXO1 Activation
por: Zhang, Zheng, et al.
Publicado: (2021)

IGF-IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway
por: He, Qi, et al.
Publicado: (2020)

Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells
por: Guo, Juan, et al.
Publicado: (2018)

Downregulation of MMP1 in MDS-derived mesenchymal stromal cells reduces the capacity to restrict MDS cell proliferation
por: Zhao, Sida, et al.
Publicado: (2017)

Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome
por: Qi, Yuekun, et al.
Publicado: (2017)

U2AF1 mutation promotes tumorigenicity through facilitating autophagy flux mediated by FOXO3a activation in myelodysplastic syndromes
por: Zhu, Yuqian, et al.
Publicado: (2021)

Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome
por: Chen, Ying, et al.
Publicado: (2023)

Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway
por: Guo, Juan, et al.
Publicado: (2017)

S100a9 deficiency accelerates MDS-associated tumor escape via PD-1/PD-L1 overexpression: S100a9 deficiency accelerates tumor escape
por: Wang, Roujia, et al.
Publicado: (2023)

PB2013: THE FREQUENCY, EVOLUTION AND SIGNIFICANCE OF GENE MUTATION IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
por: Xu, Feng, et al.
Publicado: (2023)

Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes
por: Shi, Cong, et al.
Publicado: (2022)

PB2006: MOLECULAR CLINICAL CHARACTERISTICS AND PROGNOSIS OF MDS PATIENTS WITH RUNX1 MUTATION
por: Huang, Nanfang, et al.
Publicado: (2023)

DHX9-mediated pathway contributes to the malignant phenotype of myelodysplastic syndromes
por: Huang, Nanfang, et al.
Publicado: (2023)

Decreased Expression of the FOXO3a Gene Is Associated with Poor Prognosis in Primary Gastric Adenocarcinoma Patients
por: Yang, Xiao-bo, et al.
Publicado: (2013)

Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis
por: Arinobu, Yojiro, et al.
Publicado: (2021)

High methylation of the 4-aminobutyrate aminotransferase gene predicts a poor prognosis in patients with myelodysplastic syndrome
por: Zhao, Guangjie, et al.
Publicado: (2018)

Decitabine of Reduced Dosage in Chinese Patients with Myelodysplastic Syndrome: A Retrospective Analysis
por: Li, Xiao, et al.
Publicado: (2014)

Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation
por: Shi, Lei, et al.
Publicado: (2019)

Development and validation of a novel prognosis prediction model for patients with myelodysplastic syndrome
por: Liang, Haiping, et al.
Publicado: (2022)

PB1801: MYCN IS REQUIRED FOR MAINTAINING AN ONCOGENIC CHARACTERISTICS OF LEUKEMIA CELLS IN ACUTE MYELOID LEUKEMIA
por: Huang, Nanfang, et al.
Publicado: (2023)

Hyperfibrinogenemia as a Poor Prognostic Indicator in Myelodysplastic Syndrome
por: Shi, Cong, et al.
Publicado: (2022)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
por: Kasprzak, Annika, et al.
Publicado: (2022)

Chromosomal instability correlates with poor outcome in patients with myelodysplastic syndromes irrespectively of the cytogenetic risk group
por: Heilig, Christoph E, et al.
Publicado: (2010)

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome
por: Wu, Lingyun, et al.
Publicado: (2016)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Decreased expression of PBLD correlates with poor prognosis and functions as a tumor suppressor in human hepatocellular carcinoma
por: Li, Aimin, et al.
Publicado: (2015)

c.9253-6T > c REV3L: A novel marker of poor prognosis in Myelodysplastic syndrome
por: Oliveira, Roberta Taiane G. de, et al.
Publicado: (2021)

High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma
por: Song, Shu-Shu, et al.
Publicado: (2020)

Somatic mutations predict prognosis in myelodysplastic syndrome patients with normal karyotypes
por: Zeng, Xiangzong, et al.
Publicado: (2021)

Decreased Expression of Beclin 1 Correlates Closely with Bcl-xL Expression and Poor Prognosis of Ovarian Carcinoma
por: Lin, Huan-Xin, et al.
Publicado: (2013)

GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndrome
por: Zhou, Jing‐Dong, et al.
Publicado: (2016)

Prognosis in Myelodysplastic Syndromes: The Clinical Challenge of Genomic Integration
por: Chen-Liang, Tzu-Hua
Publicado: (2021)

Higher expression of FOXOs correlates to better prognosis of bladder cancer
por: Zhang, Ying, et al.
Publicado: (2017)

Decreased Levels of Active SMAD2 Correlate with Poor Prognosis in Gastric Cancer
por: Wu, Yijun, et al.
Publicado: (2012)

Decreased expression of RASSF10 correlates with poor prognosis in patients with colorectal cancer
por: Ma, Junxun, et al.
Publicado: (2017)

Decreased let-7b is associated with poor prognosis in glioma
por: Zhang, Wanzeng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a62dunjq32gbmeohhlf9t148rv